Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
10 January 2019 | Story Leonie Bolleurs
Animal Conservation
A giraffe after a successful immobilisation capture being prepared for safe relocation.

From 2007 to 2014, the country experienced an exponential rise in rhino poaching – a growth of over 9,000%. Most illegal activities occur in the Kruger National Park.

 

Contributing to fight this battle is a group of five former students and colleagues from the UFS Department of Chemistry, now in the employment of Wildlife Pharmaceuticals. Situated in the Nelspruit area, Dr Inus Janse van Rensburg, Head of Research and Development; Lizette Janse van Rensburg, Head of Operations; Leo Kirsten, API expert; Dr Rikus Peens, API chemist; and Dr Chris Joubert, Laboratory Specialist, are working at this pharmaceutical manufacturing facility. The company specialises in the development, manufacturing, and end use of wildlife medicines.

 

With the medicines they develop, they are able to immobilise animals. Prof André Roodt, Discipline Head of the UFS Division of Inorganic Chemistry, who attended Indaba 9 with members of his research team in Skukuza, Kruger National Park, said wildlife species are being chemically immobilised for different reasons.

 

Prosecution of poachers

 

One example is of a rhino which was immobilised after a successful dehorning procedure by veterinarians and personnel of Wildlife Pharmaceuticals. As part of a programme to discourage poaching, selective DNA data collection is also conducted by some veterinarian groups for future use in the possible prosecution of individuals who are dealing with rhino horn. As soon as a rhino that was killed during poaching has been discovered, samples of the animal are obtained for a full analysis.

 

These samples are then stored on a database. Wherever rhino horn is confiscated (even internationally), the DNA is analysed, and the database may be consulted to see where the specific rhino was killed. The person in possession of the rhino horn may then be charged with the ‘killing’ of the original rhino.

 

Prof Roodt explained that the foundation of all medicines is based on active pharmaceutical ingredients (APIs) present in the finished pharmaceutical product, be it tablets, capsules, a syrup or a sterile injectable liquid. In accordance with local and international regulations and guidelines, chemists at API facilities are manufacturing these APIs globally.

 

Wildlife conservation

 

The APIs are respectively incorporated into registered finished pharmaceutical products, which are then used by registered veterinarians for chemical immobilisation and reversal of immobilisation in wildlife species.

 

According to Prof Roodt, the importance of developing appropriate chemical agents and the role of chemical manufacturing are crucial for animal conservation, with a scope far beyond the field of animal immobilisation, thus extending it to animal health, treatments, and vaccinations.

 

Besides saving our rhinos, wildlife species require immobilisation for different reasons. This can include, for example, wound treatment, relocation, and surgical procedures. “It is critical that the animals be immobilised to ensure limitation of stress to the animal, mitigate self-harm, allow safe handling of the animal, and for operator safety. These activities will be impossible to execute without chemical immobilisation of the animal,” said Prof Roodt.

 

Dr Janse van Rensburg, who received his PhD in the UFS Department of Chemistry in 2008, said the department, through exposing its students to, among others, complex equipment in labs as well as work in international labs to critically assess and benchmark their work against others, contributed to the success of his career at Wildlife Pharmaceuticals.

News Archive

Researcher part of project aimed at producing third-generation biofuels from microalgae in Germany
2016-05-09

Description: Novagreen bioreactor  Tags: Novagreen bioreactor

Some of the researchers and technicians among the tubes of the Novagreen bioreactor (Prof Grobbelaar on left)

A researcher from the University of the Free State (UFS), Prof Johan Grobbelaar, was invited to join a group of scientists recently at the Institute for Bio- and Geo-Sciences of the Research Centre Jülich, in Germany, where microalgae are used for lipid (oil) production, and then converted to kerosene for the aviation industry.

The project is probably the first of its kind to address bio-fuel production from microalgae on such a large scale.  

“The potential of algae as a fuel source is undisputed, because it was these photoautotrophic micro-organisms that were fixing sunlight energy into lipids for millions of years, generating the petroleum reserves that modern human civilisation uses today.  However, these reserves are finite, so the challenge is marrying biology with technology to produce economically-competitive fuels without harming the environment and compromising our food security.  The fundamental ability that microalgae have to produce energy-rich biomass from CO2, nutrients, and sunlight through photosynthesis for biofuels, is commonly referred to as the Third-Generation Biofuels (3G),” said Prof Grobbelaar.

The key compounds used for bio-diesel and kerosene production are the lipids and, more particularly, the triacylglyserols commonly referred to as TAGs.  These lipids, once extracted, need to be trans-esterified for biodiesel, while a further “cracking” step is required to produce kerosene.  Microalgae can store energy as lipids and/or carbohydrates. However, for biofuels, microalgae with high TAG contents are required.  A number of such algae have been isolated, and lipid contents of up to 60% have been achieved.

According to Prof Grobbelaar, the challenge is large-scale, high-volume production, since it is easy to manipulate growth conditions in the laboratory for experimental purposes.  

The AUFWIND project (AUFWIND, a German term for up-current, or new impetus) in Germany consists of three different commercially-available photobioreactor types, which are being compared for lipid production.

Description: Lipid rich chlorella Tags: Lipid rich chlorella

Manipulated Chlorella with high lipid contents (yellow) in the Novagreen bioreactor

The photobioreactors each occupies 500 m2 of land surface area, are situated next to one another, and can be monitored continuously.  The three systems are from Novagreen, IGV, and Phytolutions.  The Novagreen photobioreactor is housed in a glass house, and consist of interconnected vertical plastic tubes roughly 150 mm in diameter. The Phytolutions system is outdoors, and consists of curtains of vertical plastic tubes with a diameter of about 90 mm.  The most ambitious photobioreactor is from IGV, and consists of horizontally-layered nets housed in a plastic growth hall, where the algae are sprayed over the nets, and allowed to grow while dripping from one net to the next.

Prof Grobbelaar’s main task was to manipulate growth conditions in such a way that the microalgae converted their stored energy into lipids, and to establish protocols to run the various photobioreactors. This was accomplished in just over two months of intensive experimentation, and included modifications to the designs of the photobioreactors, the microalgal strain selection, and the replacement of the nutrient broth with a so-called balanced one.

Prof Grobbelaar has no illusions regarding the economic feasibility of the project.  However, with continued research, optimisation, and utilisation of waste resources, it is highly likely that the first long-haul flights using microalgal-derived kerosene will be possible in the not-too-distant future.

Prof Grobbelaar from the Department of Plant Sciences, although partly retired, still serves on the editorial boards of several journals. He is also involved with the examining of PhDs, many of them from abroad.  In addition, he assisted the Technology Innovation Agency of South Africa in the formulation of an algae-biotechnology and training centre.  “The chances are good that such a centre will be established in Upington, in the Northern Cape,” Prof Grobbelaar said.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept